1,843 results on '"WAGNER, JOHN E."'
Search Results
152. Analyzing the cost effectiveness of Santiago, Chile's policy of using urban forests to improve air quality
153. Reduced-Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor
154. Allogeneic Hematopoietic Stem Cell Transplantation in Adult Acute Lymphocytic Leukemia: Impact of Donor Source on Survival
155. Stable Long-Term Donor Engraftment following Reduced-Intensity Hematopoietic Cell Transplantation for Sickle Cell Disease
156. Allogeneic Hematopoietic Cell Transplantation in Children with Relapsed Acute Lymphoblastic Leukemia Isolated to the Central Nervous System
157. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa
158. Comprehensive Analysis of Pathogenic Deletion Variants in Fanconi Anemia Genes
159. Donor-derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response
160. Growth hormone treatment of patients with Fanconi Anemia after hematopoietic cell transplantation
161. Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia
162. Nonhematologic neoplasia in biallelic BRCA2 mutated Fanconi anemia.
163. MGTA-456, A CD34 Expanded Cord Blood Product, Permits Selection of Better HLA Matched Units and Results in Rapid Hematopoietic Recovery, Uniform Engraftment and Reduced Graft-Versus-Host Disease in Adults with High-Risk Hematologic Malignancies
164. CYP2B6 Variants in Cyclophosphamide Metabolism and the Incidence of Hemorrhagic Cystitis in Fanconi Anemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
165. Targeted CD45 Antibody Drug Conjugate Enables Full Mismatch Allogeneic Hematopoietic Stem Cell Transplantation in a Murine HSCT Model As a Single Agent
166. Recent Developments in Cell-based Immune Therapy for Neuroblastoma
167. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease
168. Policy analysis of a government-sanctioned management plan for a community-owned forest in Romania
169. Higher Risk of Cytomegalovirus and Aspergillus Infections in Recipients of T Cell–Depleted Unrelated Bone Marrow: Analysis of Infectious Complications in Patients Treated with T Cell Depletion Versus Immunosuppressive Therapy to Prevent Graft-versus-Host Disease
170. Peripheral Blood Grafts from Unrelated Donors Are Associated with Increased Acute and Chronic Graft-versus-Host Disease without Improved Survival
171. A Scheme for Defining Cause of Death and Its Application in the T Cell Depletion Trial
172. Chronic Graft-Versus-Host Disease (cGVHD) following Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT): Higher Response Rate In Recipients of Unrelated Donor (URD) Umbilical Cord Blood (UCB)
173. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study
174. Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation
175. Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell depletion trial): a multi-centre, randomised phase II-III trial
176. Financial analysis of diameter-limit cut stands in northern hardwoods
177. Overcomes after transplantation of cord blood or bone marrow form unrelated donors in adults with leukemia
178. Early Hematopoietic Stem Cell Transplant Is Associated With Favorable Outcomes in Children With MDS
179. Successful “in-flight” activation of natural killer cells during long-distance shipping
180. Forestry Economics
181. Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls
182. The socioeconomics and management of Santiago de Chile's public urban forests
183. Antigen-Specific T-Lymphocyte Function After Cord Blood Transplantation
184. Successful Immune Reconstitution Decreases Leukemic Relapse and Improves Survival in Recipients of Unrelated Cord Blood Transplantation
185. Results of the Cord Blood Transplantation Study (COBLT): Outcomes of Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Patients with Lysosomal and Peroxisomal Storage Diseases
186. Advances in HLA: Practical Implications for Selecting Adult Donors and Cord Blood Units
187. Double umbilical cord blood transplantation
188. Current clinical management of Fanconi anemia
189. Formation of cyclophosphamide specific DNA adducts in hematological diseases
190. 364 - Allogeneic Hematopoietic Stem Cell Transplantation (HCT) Using Reduced Intensity Conditioning with Cyclophosphamide/Fludarabine/Total Body Irradiation (TBI) with Tacrolimus, MMF, and Conditional Anti Thymocyte Globulin (ATG) for the Treatment of Hematological Malignancies
191. 113 - Lentiviral-Mediated Gene Therapy for Patients with Fanconi Anemia [Group A]: Updated Results from Global RP-L102 Clinical Trials
192. 34 - Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in Gvhd Risk without Increase Relapse Risk Compared to Historical Cyclosporine/ Methotrexate
193. Umbilical Cord Blood Transplantation
194. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors
195. Leukodystrophy and Gene Therapy with a Dimmer Switch
196. Predictors and Outcomes of Flares in Chronic Graft-Versus-Host Disease
197. Single Agent CD45-Targeted Antibody Drug Conjugate Enables Full Mismatch Allogeneic Hematopoietic Stem Cell Transplantation in a Murine HSCT Model
198. Gene Therapy for Fanconi Anemia, Complementation Group a: Updated Results from Ongoing Global Clinical Studies of RP-L102
199. Umbilical Cord Blood Transplants: Current Status and Evolving Therapies
200. Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.